BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35098684)

  • 1. The deubiquitinase OTUD1 inhibits non-small cell lung cancer progression by deubiquitinating and stabilizing KLF4.
    Ma X; Wang L; Shi G; Sun S
    Thorac Cancer; 2022 Mar; 13(5):761-770. PubMed ID: 35098684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VE-822 upregulates the deubiquitinase OTUD1 to stabilize FHL1 to inhibit the progression of lung adenocarcinoma.
    Zhang Q; Li J; Chen Z; Jiang K; Yang K; Huang F; Huang A; Zhang X; Zhang J; Wang H
    Cell Oncol (Dordr); 2023 Aug; 46(4):1001-1014. PubMed ID: 36929488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OTU deubiquitinase 5 inhibits the progression of non-small cell lung cancer via regulating p53 and PDCD5.
    Kang XY; Zhang J; Tang L; Huang L; Tong J; Fu Q
    Chem Biol Drug Des; 2020 Aug; 96(2):790-800. PubMed ID: 32248621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian tumor domain-containing protein 1 deubiquitinates and stabilizes p53.
    Piao S; Pei HZ; Huang B; Baek SH
    Cell Signal; 2017 May; 33():22-29. PubMed ID: 28216291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-25 enhances cell migration and invasion in non-small-cell lung cancer cells via ERK signaling pathway by inhibiting KLF4.
    Ding X; Zhong T; Jiang L; Huang J; Xia Y; Hu R
    Mol Med Rep; 2018 May; 17(5):7005-7016. PubMed ID: 29568911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an OTUD1 ubiquitin variant inhibitor.
    Liu Q; Mallette E; Zheng H; Zhang W
    Biochem J; 2023 Aug; 480(16):1317-1330. PubMed ID: 37589489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00852 is associated with poor prognosis in non-small cell lung cancer patients and its inhibition suppresses cancer cell proliferation and chemoresistance via the hsa-miR-145-5p/KLF4 axis.
    Tuo Z; Liang L; Zhou R
    J Gene Med; 2021 Dec; 23(12):e3384. PubMed ID: 34342374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The deubiquitinase OTUD1 inhibits colonic inflammation by suppressing RIPK1-mediated NF-κB signaling.
    Wu B; Qiang L; Zhang Y; Fu Y; Zhao M; Lei Z; Lu Z; Wei YG; Dai H; Ge Y; Liu M; Zhou X; Peng Z; Li H; Cui CP; Wang J; Zheng H; Liu CH; Zhang L
    Cell Mol Immunol; 2022 Feb; 19(2):276-289. PubMed ID: 34876703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. USP51 promotes non-small cell lung carcinoma cell stemness by deubiquitinating TWIST1.
    Chen J; Wu Z; Deng W; Tang M; Wu L; Lin N; Chen L; Fu Y; Zhao M; Chen C; Li W
    J Transl Med; 2023 Jul; 21(1):453. PubMed ID: 37422632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin induces apoptotic cell death through Bim stabilization by Sp1-mediated OTUD1 upregulation.
    Woo SM; Seo SU; Min KJ; Kwon TK
    J Pineal Res; 2022 Jan; 72(1):e12781. PubMed ID: 34826170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OTUD1 promotes hypertensive kidney fibrosis and injury by deubiquitinating CDK9 in renal epithelial cells.
    Wang MY; Yu TX; Wang QY; Han X; Hu X; Ye SJ; Long XH; Wang Y; Zhu H; Luo W; Liang G
    Acta Pharmacol Sin; 2024 Apr; 45(4):765-776. PubMed ID: 38110583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The deubiquitinase OTUD1 noncanonically suppresses Akt activation through its N-terminal intrinsically disordered region.
    Fan G; Wang F; Chen Y; Zheng Q; Xiong J; Lv Q; Wu K; Xiong J; Wei L; Li D; Zhang J; Zhang W; Li F
    Cell Rep; 2023 Jan; 42(1):111916. PubMed ID: 36640312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation.
    He Y; Jiang S; Mao C; Zheng H; Cao B; Zhang Z; Zhao J; Zeng Y; Mao X
    J Biol Chem; 2021 Sep; 297(3):101088. PubMed ID: 34416231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer.
    Li J; Cheng D; Zhu M; Yu H; Pan Z; Liu L; Geng Q; Pan H; Yan M; Yao M
    Theranostics; 2019; 9(1):179-195. PubMed ID: 30662561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OTUD1 chemosensitizes triple-negative breast cancer to doxorubicin by modulating P16 expression.
    Zhou T; Wu Y; Qian D; Tang H; Liu X; Qiu J; Wang D; Hong W; Meng X; Zheng Q
    Pathol Res Pract; 2023 Jul; 247():154571. PubMed ID: 37257246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR‑3120‑5p acts as a diagnostic biomarker in non‑small cell lung cancer and promotes cancer cell proliferation and invasion by targeting KLF4.
    Xu H; Wen Q
    Mol Med Rep; 2018 Nov; 18(5):4621-4628. PubMed ID: 30221715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The deubiquitinase OTUD1 enhances iron transport and potentiates host antitumor immunity.
    Song J; Liu T; Yin Y; Zhao W; Lin Z; Yin Y; Lu D; You F
    EMBO Rep; 2021 Feb; 22(2):e51162. PubMed ID: 33393230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Deubiquitinase OTUD1 Suppresses Secretory Neutrophil Polarization And Ameliorates Immunopathology of Periodontitis.
    Song J; Zhang Y; Bai Y; Sun X; Lu Y; Guo Y; He Y; Gao M; Chi X; Heng BC; Zhang X; Li W; Xu M; Wei Y; You F; Zhang X; Lu D; Deng X
    Adv Sci (Weinh); 2023 Oct; 10(30):e2303207. PubMed ID: 37639212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-small-cell lung cancer.
    Pan H; Pan Z; Guo F; Meng F; Zu L; Fan Y; Li Y; Li M; Du X; Zhang X; Shao Y; Wei M; Li X; Zhou Q
    BMC Cancer; 2021 Nov; 21(1):1218. PubMed ID: 34774019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.